One year acyclovir suppression of frequently recurring genital herpes: a study of efficacy, safety, virus sensitivity and antibody response.

Abstract

The efficacy of oral acyclovir 400 mg twice daily in suppressing frequently relapsing genital herpes simplex was evaluated in an open multicenter study. Seventy-one patients were treated for 12 months. During treatment, 73% of the patients were completely free of symptoms when taking the tablets continuously, and another 14% had mild symptoms such as… (More)

Topics

Cite this paper

@article{Molin1991OneYA, title={One year acyclovir suppression of frequently recurring genital herpes: a study of efficacy, safety, virus sensitivity and antibody response.}, author={Laurent Molin and M Ruhnek-Forsbeck and Bo Svennerholm}, journal={Scandinavian journal of infectious diseases. Supplementum}, year={1991}, volume={80}, pages={33-9} }